Abstract | BACKGROUND AND OBJECTIVE:
Epilepsy, the most common neurological disorder, has treatment failure rate of 20 to 25%. Inter-individual variability in drug response can be attributed to genetic polymorphism in genes encoding different drug metabolizing enzymes, drug transporters (P-gp), and enzymes involved in sodium channel biosynthesis. The present study attempted to evaluate association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and P-gp activity with treatment response in patients with epilepsy. MATERIALS AND METHODS: Patients with epilepsy on phenytoin and/or phenobarbital and/or carbamazepine were categorized into responders and non-responders as per the International League Against Epilepsy. Plasma drug concentration was estimated by high-performance liquid chromatography. P-gp activity was measured by flow cytometry using rhodamine efflux. The polymerase chain reaction (PCR-RFLP) was used to study polymorphisms of ABCB1 (C3435T), CYP2C9 (416 C > T, and 1061 A > T), and CYP2C19 (681 G > A and 636 G > A). RESULTS: Of total 117 patients enrolled in this study, genotype data was available for 115 patients. P-gp activity was higher in non-responders (n = 68) compared to responders (n = 47) (P<0.001). No association of 416 C > T and 1061 A > T in CYP2C9 or 681 G > A and 636 G > A in CYP2C19 was observed with response phenotype in genotypic analysis. Significant genotypic (odds ratio, OR = 4.5; 95% CI, 1.04 to 20.99) and allelic association (OR = 1.73; 95% CI, 1.02 to 2.95) was observed with ABCB1 C3435T and response phenotype. CONCLUSIONS: The response to antiepileptics seems to be modulated by C3435T in ABCB1 or P-gp activity. At present, role of other genetic factors in treatment responsiveness in epilepsy appears limited, warranting analysis in a larger cohort.
|
Authors | S R Taur, N B Kulkarni, P P Gandhe, B K Thelma, S H Ravat, N J Gogtay, U M Thatte |
Journal | Journal of postgraduate medicine
(J Postgrad Med)
2014 Jul-Sep
Vol. 60
Issue 3
Pg. 265-9
ISSN: 0972-2823 [Electronic] India |
PMID | 25121365
(Publication Type: Journal Article)
|
Chemical References |
- ATP Binding Cassette Transporter 1
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Anticonvulsants
- Carbamazepine
- Cytochrome P-450 CYP2C9
- Cytochrome P-450 CYP2C19
|
Topics |
- ATP Binding Cassette Transporter 1
(genetics)
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(genetics)
- Adolescent
- Adult
- Aged
- Anticonvulsants
(administration & dosage, pharmacology)
- Carbamazepine
(administration & dosage, pharmacology)
- Cross-Sectional Studies
- Cytochrome P-450 CYP2C19
(genetics)
- Cytochrome P-450 CYP2C9
(genetics)
- Drug Resistance
(genetics)
- Epilepsy
(drug therapy, genetics, metabolism)
- Female
- Gene Frequency
- Genetic Variation
- Genotype
- Humans
- Logistic Models
- Male
- Middle Aged
- Pharmacogenetics
- Polymorphism, Restriction Fragment Length
- Young Adult
|